Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.

Schroder European Alpha Inc A Acc

Ranked 39 out of 126 in - Europe Excluding UK over 12 months
All calculations are in EUR unless stated

Managed by

James Sym

James Sym joined Cazenove Capital in 2007. He is a member of the pan-European equity team with responsibility for Chemicals, Support Services, Household Goods, Personal Goods, Pharmaceuticals & Biotechnology and Telecommunication sector coverage. James manages the Schroder European Alpha and Alpha Plus funds. He graduated from St John's College, Cambridge University with a degree in Natural Sciences (Mineral Physics) and Management Studies and is a Chartered Financial Analyst. He has six years of investment experience.

Objective

Showing fund performance globally. You can view performance in individual jurisdictions.

Performance

Europe Excluding UK over : 31/10/2016 - 31/10/2017

Total Return

Quarterly Performance

to 29/09/2017 Annual Q1 Q2 Q3 Q4
2017 4.7% 3.5% 3.6%
2016 6.5% -7.8% -1.6% 5.4% 11.4%
2015 18.6% 23.4% -0.3% -9.5% 6.5%
2014 7.4% 11.6% 1.1% -2.5% -2.4%
2013 36.1% 5.0% 3.8% 15.4% 8.3%
2012 11.9% 5.7%

Month by Month Performance

Returns Vs Risk

Asset Allocation

Breakdown

30/06/2017

Top 10 Holdings

Stock Size
Koninklijke KPN NV ORD 4.85
Bayer AG ORD 4.68
KBC Groep NV ORD 4.34
Continental AG ORD 3.93
Deutsche Telekom AG ORD 3.81
Novo Nordisk A/S ORD 3.72
Lundin Petroleum AB ORD 3.67
ING Groep NV ORD 3.55
Aurelius Equity Opportunities SE & Co KGaA ORD 3.28
Bpost SA ORD 3.17
30/06/2017

Registered For Sale In

  1. United Kingdom

Fund Info

  • Launch date02/05/2012
  • Share Class size46Mn
  • Base currencyGBP
  • ISIN GB00B79FC312

Purchase Info

  • Min. initial investment1,000
  • Min. regular additional investment50

Charges

  • Annual management1.50%
  • Initial investment0

Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated).